Suchergebnisse - "Paulshus Sundlisæter, Nina"

PubPharm (9)

1

Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria : data from the ARCTIC study

enthalten in: Annals of the rheumatic diseases | 2024

von Melokhina, V. | Paulshus Sundlisæter, N. | Sexton, J. | +7

2

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity

enthalten in: RMD open | 2024

von Holten, K. | Paulshus Sundlisæter, N. | Sexton, J. | +18

3

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission : a randomised, open label, non-inferiority trial

enthalten in: Annals of the rheumatic diseases | 2023

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +16

CommentIn: Ann Intern Med. 2023 Dec;176(12):JC139. - PMID 38048575

4

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control

enthalten in: JAMA | 2023

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +4

ErratumIn: JAMA. 2023 May 9;329(18):1612. - PMID 37159047

5

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

enthalten in: RMD open | 2022

von Paulshus Sundlisæter, N. | Sundin, U. | Aga, A. | +6

CommentIn: RMD Open. 2022 Sep;8(2):. - PMID 36180100

6

Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis-Reply

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Haavardsholm, E.

CommentOn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

7

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission : The ARCTIC REWIND Randomized Clinical Trial

enthalten in: JAMA | 2021

von Lillegraven, S. | Paulshus Sundlisæter, N. | Aga, A. | +18

CommentIn: JAMA. 2021 Sep 7;326(9):872-873. - PMID 34547087

8

Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol

enthalten in: Rheumatology (Oxford, England) | 2018

von Paulshus Sundlisæter, N. | Olsen, I. | Aga, A. | +17

9

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis : associations to future good radiographic and physical outcomes

enthalten in: Annals of the rheumatic diseases | 2018

von Paulshus Sundlisæter, N. | Aga, A. | Olsen, I. | +17

1
[1]